The PE Ratio as of June 2026 (TTM) for WuXi Biologics (Cayman) Inc. (WXXWY) is 21.96

According to WuXi Biologics (Cayman) Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 21.96. This represents a change of 125.96% compared to the average of 9.72 of the last 4 quarters.

WuXi Biologics (Cayman) Inc. (WXXWY) Historical PE Ratio (quarterly & annually)

How has WXXWY PE Ratio performed in the past?

The mean historical PE Ratio of WuXi Biologics (Cayman) Inc. over the last ten years is 100.47. The current 21.96 PE Ratio has changed 2.09% with respect to the historical average. Over the past ten years (40 quarters), WXXWY's PE Ratio was at its highest in in the December 2016 quarter at 1.25K. The PE Ratio was at its lowest in in the June 2024 quarter at 7.62.

WuXi Biologics (Cayman) Inc. (WXXWY) PE Ratio by Quarter and Year

Discovering the peaks and valleys of WuXi Biologics (Cayman) Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

WuXi Biologics (Cayman) Inc. (WXXWY) Average PE Ratio

How has WXXWY PE Ratio performed in the past?

The current PE Ratio of WuXi Biologics (Cayman) Inc. (WXXWY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

WuXi Biologics (Cayman) Inc. (WXXWY) PE Ratio vs. Peers

How is WXXWY’s PE Ratio compared to its peers?

WuXi Biologics (Cayman) Inc.’s PE Ratio is greater than Inhibikase Therapeutics, Inc. (-3.24), less than Corcept Therapeutics Incorporated (178.23), greater than Cardio Diagnostics Holdings, Inc. (-0.85), greater than Prometheus Biosciences, Inc. (-57.28), greater than Revolution Medicines, Inc. (-22.78), greater than Nuvalent, Inc. (-21.56), greater than RAPT Therapeutics, Inc. (-14.81), greater than Syndax Pharmaceuticals, Inc. (-6.78), greater than EQRx, Inc. (5.40), greater than Panbela Therapeutics, Inc. (-0.00), greater than Virpax Pharmaceuticals, Inc. (-0.00), greater than Revelation Biosciences, Inc. (-0.35), greater than Biodexa Pharmaceuticals Plc (-0.03), greater than Praxis Precision Medicines, Inc. (-23.88), greater than Regen BioPharma, Inc. (-0.03), greater than Regen BioPharma, Inc. (-0.03), greater than Mind Cure Health Inc. (-4.74), greater than SB Technology Holdings, Inc. (-1.19), greater than Adagene Inc. (-7.58),

Build a custom stock screener for WuXi Biologics (Cayman) Inc. (WXXWY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like WuXi Biologics (Cayman) Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

WuXi Biologics (Cayman) Inc. (WXXWY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like WuXi Biologics (Cayman) Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.